SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SYNCOM FORMULATIONS (INDIA) LT

BSE: 524470 22 Aug 2025
Healthcare
₹ 17.37
Syncom Formulations (India) Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SYNCOM FORMULATIONS (INDIA) LT - Share Price & Details

Market Cap
₹1,631
High /Low
27.9 / 14.1
Stock P/E
28.3
Book Value
₹3.64
Dividend Yield
0.0
ROCE
18.8
ROE
₹15.7
Face Value
1.0
PEG Ratio
0.79
EVEBITDA
₹20.1
Debt
4.58
CMP / FCF
-457.0
Debt to equity
₹0.01
NP Ann
49.4
High price all time
27.9
Piotroski score
₹8.0
Graham Number
7.08
No. Eq. Shares
94.0
Net CF
₹-62.7
Net profit
57.6
Price to book value
4.76
Interest Coverage
₹105.0
Low price all time
0.32
Industry PE
32.8
Reserves
₹248
Free Cash Flow
₹13.5

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
SYNCOM FORMULATIONS (INDIA) LT1225.67157.291165.470.211,63128.3
JAGSONPAL PHARMACEUTICALS LTD.784.37107.95756.121.58156436.7
Bajaj Healthcare Limited1497.14118.341488.363.75141130.0

Peer Comparison Chart


About SYNCOM FORMULATIONS (INDIA) LT

Syncom Formulations (India) Ltd., with Security Code 524470, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Syncom Formulations (India) Says Rahul Vijay Bankda Appointed As CFO Effective August 9

(13 Aug 2025)
Syncom Formulations (India) Ltd NSE:SYNCOMF:
Read more →

Syncom Formulations (India) schedules AGM

(12 Aug 2025)
Syncom Formulations (India) announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025. More News.
Read more →

Syncom Formulations Reports Strong Sales Growth Amid Score Evaluation Adjustment

(09 Aug 2025)
Syncom Formulations (India) has announced its financial results for the quarter ending June 2025, showcasing a significant increase in net sales to Rs...
Read more →

Syncom Formulations (India) consolidated net profit rises 106.42% in the June 2025 quarter

(08 Aug 2025)
Sales rise 33.97% to Rs 116.90 crore. Net profit of Syncom Formulations (India) rose 106.42% to Rs 15.75 crore in the quarter ended June 2025 as against Rs...
Read more →

Syncom Formulations Announces Strategic Amendments to AOA and MOA

(08 Aug 2025)
The latest update is out from Syncom Formulation (India) Ltd. ( ($IN:SYNCOMF) ). Syncom Formulations (India) Ltd. has announced amendments...
Read more →

Syncom Formulations (India) Limited (SYNCOMF) Sees Unusual Trading Volume - Free Bull & Bear Market Updates

(04 Aug 2025)
Syncom Formulations (India) Limited (SYNCOMF) Sees Unusual Trading Volume ✌️【Stock Buzz】✌️ Join thousands of investors who've multiplied...
Read more →

Company Updates